Abiomed (NASDAQ: ABMD) the successful results of the first-in-human early feasibility study of the preCARDIA system.
Healthcare Press Releases
HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally invasive cardiac care globally, a major milestone in ongoing pre-clinical trials of the HeartPoint Global Implant System (HPGS) in Israel.
Polycarbin, Inc. the closing of a $2M seed round with funding from Ringbolt Capital, VoLo Earth Ventures, along with several notable angel investors to scale the only Closed-Loop solution for single-use plastics in the life science and healthcare sector.
CAMRIS International, LLC, an HJF Company, its involvement in COVID-19 vaccine research by the Walter Reed Army Institute of Research (WRAIR).
Watson Guide I.P. LLC, a medical device company (La Canada, California) focused on developing innovative full arch dental guides for safer, more predictable guided full arch restorations, that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, it has expanded the BD COR™ System to include a new MX instrument for high-throughput molecular testing for infectious diseases.
Rimini Street, Inc. (NASDAQ: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, that CHG Healthcare.
REV Group, Inc. ( NYSE: REVG) which includes companies that manufacture Horton®, AEV®, Road Rescue®, Wheeled Coach® and Leader® brand ambulances, several recent agreements that expand the prospects of alternative fuel-powered ambulances in the U.S. and abroad.
Standard Bariatrics®, Inc. (SBI), a Cincinnati-based company focused on developing medical devices for surgical treatments of obesity, it reached a $1M sales milestone during November 2021 for the Titan SGS™.
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant.